Companion Animal Diagnostics Market Growth, Size, Trends Analysis - By Product, By Technology, By Application, By Animal, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Companion Animal Diagnostics Market Introduction and Overview

According to SPER market research, 'Global Companion Animal Diagnostics Market Size- By Product, By Technology, By Application, By Animal, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Companion Animal Diagnostics Market is predicted to reach 8.4 billion by 2034 with a CAGR of 9.05%.

A molecular diagnostic method for identifying chronic illnesses in companion animals is called companion animal diagnostics. Many chronic diseases in animals are believed to be best diagnosed and defined by companion animal diagnostics. Disorders are identified using a variety of diagnostic techniques, such as uranalysis, clinical biochemistry, immunodiagnostic testing, and molecular diagnostics.

There is a severe lack of qualified veterinarians and pathologists in the worldwide animal healthcare industry, especially in developing regions like Asia Pacific and Latin America. Despite a significant demand for veterinary services, nations like China and Brazil lack skilled veterinarians. This disparity impedes the industry's expansion and has an impact on the uptake of cutting-edge diagnostic tools, which are crucial for companion animals.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Technology, By Application, By Animal, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered IDEXX, Zoetis Services LLC, Mars, Incorporated, FUJIFILM Corporation, bioMA(C)rieux, Thermo Fisher Scientific Inc, Virbac, Neogen Corporation, INDICAL BIOSCIENCE GmbH, IDvet, Randox Laboratories Ltd, Shenzhen Mindray Animal Medical Technology Co, LTD, Bionote USA Inc, Boule, EUROIMMUN Medizinische Labordiagnostika AG, Biopanda Reagents Ltd, Nova Biomedical.

Companion Animal Diagnostics Market Segmentation:

By Product: Based on the Product, Global Companion Animal Diagnostics Market is segmented as; Consumables, Instruments.

By Technology: Based on the Technology, Global Companion Animal Diagnostics Market is segmented as; Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics, Other Companion Animal Diagnostics Technologies.

By Animal: Based on the Animal, Global Companion Animal Diagnostics Market is segmented as; Dogs, Cats, Horses and Other Companion Animals.

By Application: Based on the Application, Global Companion Animal Diagnostics Market is segmented as; Clinical Pathology, Bacteriology, Virology, Parasitology

Product Code: HLCA2504

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Companion Animal Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Companion Animal Diagnostics Market

7. Global Companion Animal Diagnostics Market, By Product (USD Million) 2021-2034

7.1. Consumables
7.2. Instruments

8. Global Companion Animal Diagnostics Market, By Technology (USD Million) 2021-2034

8.1. Clinical Biochemistry
8.2. Immunodiagnostics
8.3. Hematology
8.4. Urinalysis
8.5. Molecular Diagnostics

9. Global Companion Animal Diagnostics Market, By Application (USD Million) 2021-2034

9.1. Clinical Pathology
9.2. Bacteriology
9.3. Virology
9.4. Parasitology
9.5. Others Applications

10. Global Companion Animal Diagnostics Market, By Animal (USD Million) 2021-2034

10.1. Dogs
10.2. Cats
10.3. Horses
10.4. Other Companion Animals

11. Global Companion Animal Diagnostics Market, By End User (USD Million) 2021-2034

11.1. Diagnostic Laboratories
11.2. Veterinary Hospitals and Clinics
11.3. Research Institutes & Universities
11.4. Home-care Settings

12. Global Companion Animal Diagnostics Market (USD Million) 2021-2034

12.1. Global Companion Animal Diagnostics Market Size and Market Share

13. Global Companion Animal Diagnostics Market, By Region (USD Million) 2021-2034

13.1. Asia-Pacific
- 13.1.1. Australia
- 13.1.2. China
- 13.1.3. India
- 13.1.4. Japan
- 13.1.5. South Korea
- 13.1.6. Rest of Asia-Pacific
13.2. Europe
- 13.2.1. France
- 13.2.2. Germany
- 13.2.3. Italy
- 13.2.4. Spain
- 13.2.5. United Kingdom
- 13.2.6. Rest of Europe
13.3. Middle East and Africa
- 13.3.1. Kingdom of Saudi Arabia
- 13.3.2. United Arab Emirates
- 13.3.3. Qatar
- 13.3.4. South Africa
- 13.3.5. Egypt
- 13.3.6. Morocco
- 13.3.7. Nigeria
- 13.3.8. Rest of Middle-East and Africa
13.4. North America
- 13.4.1. Canada
- 13.4.2. Mexico
- 13.4.3. United States
13.5. Latin America
- 13.5.1. Argentina
- 13.5.2. Brazil
- 13.5.3. Rest of Latin America

14. Company Profile

14.1. IDEXX
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
14.2. Zoetis Services LLC
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
14.3. Mars, Incorporated
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
14.4. FUJIFILM Corporation
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
14.5. bioMerieux
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
14.6. Thermo Fisher Scientific Inc
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
14.7. Virbac
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
14.8. Neogen Corporation
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
14.9. INDICAL BIOSCIENCE GmbH
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
14.10. IDvet
- 14.10.1. Company details
- 14.10.2. Financial outlook
- 14.10.3. Product summary
- 14.10.4. Recent developments
14.11. Randox Laboratories Ltd
- 14.11.1. Company details
- 14.11.2. Financial outlook
- 14.11.3. Product summary
- 14.11.4. Recent developments
14.12. Shenzhen Mindray Animal Medical Technology Co, LTD
- 14.12.1. Company details
- 14.12.2. Financial outlook
- 14.12.3. Product summary
- 14.12.4. Recent developments
14.13. Bionote USA Inc
- 14.13.1. Company details
- 14.13.2. Financial outlook
- 14.13.3. Product summary
- 14.13.4. Recent developments
14.14. Boule
- 14.14.1. Company details
- 14.14.2. Financial outlook
- 14.14.3. Product summary
- 14.14.4. Recent developments
14.15. EUROIMMUN Medizinische Labordiagnostika AG
- 14.15.1. Company details
- 14.15.2. Financial outlook
- 14.15.3. Product summary
- 14.15.4. Recent developments
14.16. Biopanda Reagents Ltd
- 14.16.1. Company details
- 14.16.2. Financial outlook
- 14.16.3. Product summary
- 14.16.4. Recent developments
14.17. Nova Biomedical
- 14.17.1. Company details
- 14.17.2. Financial outlook
- 14.17.3. Product summary
- 14.17.4. Recent developments
14.18. Others